//October

Iksuda Therapeutics enters license agreement with University of Goettingen to develop a new generation of antibody drug conjugates

Iksuda Therapeutics enters license agreement with University of Goettingen to develop a new generation of antibody drug conjugates Iksuda licenses novel protein-alkylating, tumour-activated pro-drug payload series to develop ADCs [...]

By |2020-10-13T10:22:25+00:00October 13th, 2020|News|0 Comments

Ground Breaking cancer diagnostics spin out that looks to save up to 2,000 lives each year joins Newcastle Helix eco-system

The Biosphere, a specialist lab facility on Newcastle Helix, has welcomed yet another Newcastle University spin-out, who has developed and commercialised a prognostic test for early-stage skin cancer. Formed [...]

By |2020-10-07T09:03:34+00:00October 7th, 2020|News|0 Comments